DALLAS–(BUSINESS WIRE)–OncoNano Medicine, Inc. (“OncoNano”), a clinical-stage oncology company advancing targeted cancer therapies using proprietary polymer technologies, today announced the appointment of Brett P. Giroir, MD, as Chief Executive Officer. Dr. Giroir, who has served as Chairman of the Board of Directors and Interim CEO, will lead the company as it advances its clinical and preclinical programs and expands strategic partnerships. Dr. Giroir is a physician-scientist and former fo
